Intrauterine Inflammation, Excessive Fetal Growth and Respiratory Morbidities in Moderate-To-Late Preterm Neonates

Kyoko Yokoi1, Osuke Iwata1, Satoru Kobayashi2

  • 1Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Neonatology
|December 17, 2023
PubMed

Insights

Intrauterine inflammation, indicated by chorioamnionitis, increases respiratory morbidities in moderate-to-late preterm neonates. Early prediction and monitoring are crucial for these vulnerable infants.

Area of Science:

  • Neonatal Medicine
  • Perinatal Research
  • Pediatric Respiratory Medicine

Background:

  • Respiratory morbidities pose significant risks to neonates, necessitating early prediction.
  • Intrauterine inflammation is a known factor in respiratory issues for very preterm and term infants.
  • The impact of intrauterine inflammation on moderate-to-late preterm neonates remains less understood.

Purpose of the Study:

  • To investigate the association between intrauterine inflammation and respiratory morbidities in moderate-to-late preterm neonates (32+0 to 36+6 weeks gestation).

Main Methods:

  • A retrospective observational study of 242 neonates born between 32+0 and 34+6 weeks gestation.
  • Respiratory morbidities were defined as requiring invasive mechanical ventilation for longer than 3 days.
  • Multivariable logistic regression analysis assessed the correlation between respiratory morbidities and intrauterine inflammation markers.

Main Results:

  • Chorioamnionitis (OR: 2.8) was significantly associated with increased respiratory morbidities.
  • Respiratory distress syndrome (OR: 9.1), lower gestational age, higher birth-weight z-score, and lower cord blood pH were also predictive.
  • The model identified key factors contributing to respiratory morbidities in this cohort.

Conclusions:

  • Intrauterine inflammation, specifically chorioamnionitis, is linked to respiratory morbidities in moderate-to-late preterm neonates.
  • The detrimental effects of intrauterine inflammation on lung development appear consistent across various gestational ages.
  • Current neonatal intensive care unit admission policies based solely on birth weight may overlook at-risk neonates.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
991
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
293
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
312
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K